Ticker
HROW
Analysis
Harrow, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to HROW.
Harrow, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to HROW.
HROW
Stock
$1.60B
Health Technology
Pharmaceuticals: Major
USD
Harrow, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
VERKAZIA is now supported by a comprehensive commercial strategy focused on physician education, patient access, and affordability initiatives to ensure dependable supply and re...
Harrow to Present at William Blair’s 46th Annual Growth Stock Conference
First Quarter 2026 and Selected Highlights: VEVYE® delivered record new and total prescription performance (despite an approximate 18% decline in the overall branded dry eye cat...
Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on May 12, 2026NASHVILLE, Tenn., April 27, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading...
Reimbursement for Office-Based Utilization to Begin in July 2026 NASHVILLE, Tenn., April 16, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading
Review valuation context for Harrow, Inc..
Review future growth context for Harrow, Inc..
Review past performance context for Harrow, Inc..
Review financial health context for Harrow, Inc..
Review dividend context for Harrow, Inc..
Review management context for Harrow, Inc..
Review ownership context for Harrow, Inc..
Review other information context for Harrow, Inc..
Review community context for Harrow, Inc..